Franco-Vidal Valérie, Nguyen Dinh-Qui, Guerin Jean, Darrouzet Vincent
Department of Otolaryngology, University Hospital of Bordeaux, France.
Otol Neurotol. 2004 Sep;25(5):805-10. doi: 10.1097/00129492-200409000-00026.
The objectives of this study were to study the role of herpes virus reactivation in the onset of delayed facial paralysis (DFP) occurring more than 72 hours after vestibular schwannoma (VS) surgery and to advocate specific medical management.
We conducted a retrospective case review.
University-based, tertiary care center.
Eight patients managed for DFP in a series of 348 patients operated for a VS.
Patients were evaluated and graded according to the House and Brackmann grading system and followed up for 1 year. A serologic search for specific antiherpes simplex viruses type 1 and 2 (HSV-2) and varicella zoster virus (VZV) antibodies at the onset of DFP and 2 weeks later was possible in three cases. Seven of the eight patients were given intravenous acyclovir (30 mg/kg/ for 5 days) and methylprednisolone (2 mg.kg/ for 7 days).
Mean delay of DFP onset was 8.75 days. All treated patients had a House and Brackmann Grade 1 recovery: mean time to recovery was 40.4 days. The last one had only a Grade 3 recovery because he could not be treated because of postoperative transient psychiatric problems. Serologic testing in those patients in whom it could be done revealed either a high level of anti HSV or VZV antibodies at the time of onset or a dramatic increase in anti-HSV or anti-VZV antibodies between the two samples, strongly suggesting an HSV or VZV reactivation.
HSV or VZV reactivation might be responsible for most cases of DFPs, thus suggesting the usefulness of immediate steroid and acyclovir administration to obtain total recovery. The viral reactivation mechanism is comparable to that already suspected in DFP occurring with the same delay in middle ear surgical procedures.
本研究的目的是探讨疱疹病毒再激活在前庭神经鞘瘤(VS)手术后72小时以上发生的迟发性面瘫(DFP)发病中的作用,并提倡特定的药物治疗。
我们进行了一项回顾性病例分析。
大学附属三级医疗中心。
在348例接受VS手术的患者中,有8例患者出现DFP。
根据House-Brackmann分级系统对患者进行评估和分级,并随访1年。3例患者在DFP发病时及发病2周后进行了针对1型和2型单纯疱疹病毒(HSV-2)及水痘带状疱疹病毒(VZV)的血清学检测。8例患者中有7例接受了静脉注射阿昔洛韦(30mg/kg,共5天)和甲基泼尼松龙(2mg/kg,共7天)治疗。
DFP发病的平均延迟时间为8.75天。所有接受治疗的患者House-Brackmann分级均恢复至1级:平均恢复时间为40.4天。最后1例患者仅恢复至3级,原因是术后出现短暂精神问题而未能接受治疗。在可进行血清学检测的患者中,检测结果显示发病时抗HSV或VZV抗体水平较高,或两份样本之间抗HSV或抗VZV抗体显著升高,强烈提示HSV或VZV再激活。
HSV或VZV再激活可能是大多数DFP病例的病因,因此提示立即给予类固醇和阿昔洛韦治疗以实现完全恢复是有用的。病毒再激活机制与中耳手术中出现相同延迟的DFP中已怀疑的机制类似。